These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 28629183)

  • 1. An Amyloidogenic Sequence at the N-Terminus of the Androgen Receptor Impacts Polyglutamine Aggregation.
    Oppong E; Stier G; Gaal M; Seeger R; Stoeck M; Delsuc MA; Cato ACB; Kieffer B
    Biomolecules; 2017 Jun; 7(2):. PubMed ID: 28629183
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reversible amyloid fiber formation in the N terminus of androgen receptor.
    Asencio-Hernández J; Ruhlmann C; McEwen A; Eberling P; Nominé Y; Céraline J; Starck JP; Delsuc MA
    Chembiochem; 2014 Nov; 15(16):2370-3. PubMed ID: 25212277
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NMR WaterLOGSY Reveals Weak Binding of Bisphenol A with Amyloid Fibers of a Conserved 11 Residue Peptide from Androgen Receptor.
    Asencio-Hernández J; Kieffer B; Delsuc MA
    PLoS One; 2016; 11(9):e0161948. PubMed ID: 27583469
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Involvement of three glutamine tracts in human androgen receptor transactivation.
    Harada N; Mitani T; Higashimura Y; Yamaji R; Okamoto K; Nakano Y; Inui H
    J Steroid Biochem Mol Biol; 2010 Jan; 118(1-2):77-84. PubMed ID: 19833203
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Toxic and non-toxic aggregates from the SBMA and normal forms of androgen receptor have distinct oligomeric structures.
    Jochum T; Ritz ME; Schuster C; Funderburk SF; Jehle K; Schmitz K; Brinkmann F; Hirtz M; Moss D; Cato AC
    Biochim Biophys Acta; 2012 Jun; 1822(6):1070-8. PubMed ID: 22366762
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of p160-mediated coactivation with increasing androgen receptor polyglutamine length.
    Irvine RA; Ma H; Yu MC; Ross RK; Stallcup MR; Coetzee GA
    Hum Mol Genet; 2000 Jan; 9(2):267-74. PubMed ID: 10607837
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of the protein context on the polyglutamine length-dependent elongation of amyloid fibrils.
    Huynen C; Willet N; Buell AK; Duwez AS; Jerôme C; Dumoulin M
    Biochim Biophys Acta; 2015 Mar; 1854(3):239-48. PubMed ID: 25489872
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Consequences of poly-glutamine repeat length for the conformation and folding of the androgen receptor amino-terminal domain.
    Davies P; Watt K; Kelly SM; Clark C; Price NC; McEwan IJ
    J Mol Endocrinol; 2008 Nov; 41(5):301-14. PubMed ID: 18762554
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural and functional consequences of glutamine tract variation in the androgen receptor.
    Buchanan G; Yang M; Cheong A; Harris JM; Irvine RA; Lambert PF; Moore NL; Raynor M; Neufing PJ; Coetzee GA; Tilley WD
    Hum Mol Genet; 2004 Aug; 13(16):1677-92. PubMed ID: 15198988
    [TBL] [Abstract][Full Text] [Related]  

  • 10. N-terminal polyglutamine-containing fragments inhibit androgen receptor transactivation function.
    Schiffer NW; Céraline J; Hartl FU; Broadley SA
    Biol Chem; 2008 Dec; 389(12):1455-66. PubMed ID: 18844449
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Backbone 1H, 15N, 13C NMR assignment of the 518-627 fragment of the androgen receptor encompassing N-terminal and DNA binding domains.
    Meyer S; Wang YH; Pérez-Escrivà P; Kieffer B
    Biomol NMR Assign; 2016 Apr; 10(1):175-8. PubMed ID: 26732902
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of the Androgen Receptor by Antiandrogens in Spinobulbar Muscle Atrophy.
    Baniahmad A
    J Mol Neurosci; 2016 Mar; 58(3):343-7. PubMed ID: 26563449
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distinct recognition modes of FXXLF and LXXLL motifs by the androgen receptor.
    Dubbink HJ; Hersmus R; Verma CS; van der Korput HA; Berrevoets CA; van Tol J; Ziel-van der Made AC; Brinkmann AO; Pike AC; Trapman J
    Mol Endocrinol; 2004 Sep; 18(9):2132-50. PubMed ID: 15178743
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polyglutamine aggregates impair lipid membrane integrity and enhance lipid membrane rigidity.
    Ho CS; Khadka NK; She F; Cai J; Pan J
    Biochim Biophys Acta; 2016 Apr; 1858(4):661-70. PubMed ID: 26806158
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of the conformation of the androgen receptor in spinal bulbar muscular atrophy by atomic force microscopy.
    Jochum T; Cato AC
    Methods Mol Biol; 2014; 1204():197-204. PubMed ID: 25182772
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Androgen receptor ligand-binding domain interaction and nuclear receptor specificity of FXXLF and LXXLL motifs as determined by L/F swapping.
    Dubbink HJ; Hersmus R; Pike AC; Molier M; Brinkmann AO; Jenster G; Trapman J
    Mol Endocrinol; 2006 Aug; 20(8):1742-55. PubMed ID: 16627595
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disrupting SUMOylation enhances transcriptional function and ameliorates polyglutamine androgen receptor-mediated disease.
    Chua JP; Reddy SL; Yu Z; Giorgetti E; Montie HL; Mukherjee S; Higgins J; McEachin RC; Robins DM; Merry DE; Iñiguez-Lluhí JA; Lieberman AP
    J Clin Invest; 2015 Feb; 125(2):831-45. PubMed ID: 25607844
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective role of an NH2-terminal WxxLF motif for aberrant androgen receptor activation in androgen depletion independent prostate cancer cells.
    Dehm SM; Regan KM; Schmidt LJ; Tindall DJ
    Cancer Res; 2007 Oct; 67(20):10067-77. PubMed ID: 17942941
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The N terminus of the small heat shock protein HSPB7 drives its polyQ aggregation-suppressing activity.
    Wu D; Vonk JJ; Salles F; Vonk D; Haslbeck M; Melki R; Bergink S; Kampinga HH
    J Biol Chem; 2019 Jun; 294(25):9985-9994. PubMed ID: 31097540
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amino acids 3-13 and amino acids in and flanking the 23FxxLF27 motif modulate the interaction between the N-terminal and ligand-binding domain of the androgen receptor.
    Steketee K; Berrevoets CA; Dubbink HJ; Doesburg P; Hersmus R; Brinkmann AO; Trapman J
    Eur J Biochem; 2002 Dec; 269(23):5780-91. PubMed ID: 12444966
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.